Stocklytics Platform
Asset logo for symbol LMAT
LeMaitre Vascular
LMAT76
$85.56arrow_drop_down1.06%-$0.92
High Quality
High Growth
Asset logo for symbol LMAT
LMAT76

$85.56

arrow_drop_down1.06%

Performance History

Chart placeholder
Key Stats
Open$86.63
Prev. Close$87.02
EPS1.51
Next Earnings DateAug 1, 2024
LOWHIGH
Day Range85.14
88.75
52 Week Range44.27
88.75
Ratios
EPS1.51

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$846.10
Perf. (24h)
arrow_drop_down6.56%-$59.48
Market Cap$815.39B
Price$566.39
Perf. (24h)
arrow_drop_down1.20%-$6.89
Market Cap$464.20B
Price$156.91
Perf. (24h)
arrow_drop_up0.21%$0.33
Market Cap$376.83B
Price$123.03
Perf. (24h)
arrow_drop_down2.26%-$2.85
Market Cap$318.85B

About LeMaitre Vascular (LMAT)

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers restoreflow allografts; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access in patients with or without a previously-failed synthetic graft; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. George W. LeMaitre
Headquarters
Burlington
Employees
591
Exchange
NASDAQ
add LeMaitre Vascular  to watchlist

Keep an eye on LeMaitre Vascular

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is LeMaitre Vascular 's (LMAT) price per share?

The current price per share for LeMaitre Vascular (LMAT) is $85.56. The stock has seen a price change of -$0.92 recently, indicating a -1.06% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for LeMaitre Vascular (LMAT)?

For LeMaitre Vascular (LMAT), the 52-week high is $88.75, which is 3.73% from the current price. The 52-week low is $44.27, the current price is 93.27% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is LeMaitre Vascular (LMAT) a growth stock?

LeMaitre Vascular (LMAT) has shown an average price growth of 0.41% over the past three years. It has received a score of 70 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying LeMaitre Vascular as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is LeMaitre Vascular (LMAT) stock price performance year to date (YTD)?

As of the latest data, LeMaitre Vascular (LMAT) has a year-to-date price change of 50.87%. Over the past month, the stock has experienced a price change of 5.14%. Over the last three months, the change has been 35.72%. Over the past six months, the figure is 50.34%. Looking at a longer horizon, the five-year price change stands at 184.73%.

help
Is LeMaitre Vascular (LMAT) a profitable company?

LeMaitre Vascular (LMAT) has a net income of $30.1M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 62.52% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 22.2% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $193.48M, with a revenue growth rate of 19.69%, providing insight into the company's sales performance and growth. The gross profit is $120.96M. Operating income is noted at $37.08M. Furthermore, the EBITDA is $52.55M.

help
What is the market capitalization of LeMaitre Vascular (LMAT)?

LeMaitre Vascular (LMAT) has a market capitalization of $1.94B. The average daily trading volume is 122.96K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level